Antiplatelet and Anticoagulation Therapy in Structural Heart Disease Interventions Beyond TAVI

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|23|9|1328-1333

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.23, Iss.9, 2017-04, pp. : 1328-1333

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antiplatelet Therapy in TAVI: Current Clinical Practice and Recommendations

By  

Current Pharmaceutical Design, Vol. 22, Iss. 13, 2016-04 ,pp. : 1888-1895

Bentham Science Publishers

Access to resources Recommend Favorite

Historical Hallmarks of Anticoagulation and Antiplatelet Agents

By  

Current Pharmaceutical Design, Vol. 22, Iss. 13, 2016-04 ,pp. : 1857-1861

Bentham Science Publishers

Access to resources Recommend Favorite

Anticoagulation therapy the answer to treating and preventing thromboembolic disease in children

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 21, Iss. 1, 2005-01 ,pp. : 6-11

Adis International

Access to resources Recommend Favorite

Heterogeneity of Efficacy and Safety of Antiplatelet Therapy in Cardiovascular and Cerebrovascular Disease

By Gebel James M.  

American Journal of Cardiovascular Drugs, Vol. 10, Iss. 2, 2010-04 ,pp. : 115-124

Adis International

Access to resources Recommend Favorite

Challenges and Perspectives of Antiplatelet Therapy in Patients with Diabetes Mellitus and Coronary Artery Disease

By  

Current Pharmaceutical Design, Vol. 18, Iss. 33, 2012-11 ,pp. : 5273-5293

Bentham Science Publishers

Access to resources Recommend Favorite